Representativeness in Premarketing vs Postmarketing US Food and Drug Administration Trials

被引：1
|
作者：
Unger, Joseph M. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M3-C102,POB 19024, Seattle, WA 98109 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2021.7159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
    Joshua D. Wallach
    Anita T. Luxkaranayagam
    Sanket S. Dhruva
    Jennifer E. Miller
    Joseph S. Ross
    BMC Medicine, 17
  • [32] Dermatology-related postmarketing study commitments to the Food and Drug Administration
    Bognet, Rachel A.
    Chiang, David S.
    Katz, Kenneth A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 721 - 723
  • [33] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [34] Urokinase and the US food and drug administration
    Ouriel, K
    JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
  • [35] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
  • [36] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [37] Core limitations in clinical trials leading to anticancer drug approvals by the US Food and Drug Administration.
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
  • [39] Integrated Drug Reviews at the US Food and Drug Administration
    Woodcock, Janet
    Stein, Peter
    Bugin, Kevin
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
  • [40] Surgical Innovation and the US Food and Drug Administration
    Cundiff, Geoffrey W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
12345